IBSA Pharma Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $956,604 | 50,512 | 62.7% |
| Consulting Fee | $285,525 | 365 | 18.7% |
| Unspecified | $202,991 | 18 | 13.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $36,970 | 66 | 2.4% |
| Honoraria | $28,551 | 15 | 1.9% |
| Travel and Lodging | $16,238 | 51 | 1.1% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| Comparison of Levothyroxine Formulation in Hypothyroid Patients with Enteral Feeding | $73,881 | 0 | 2 |
| Liquid Thyroxine Outcomes in Hypothyroid Patients with Small Intestinal Bacterial Overgrowth Syndrome (SIBO) | $58,940 | 0 | 4 |
| Efficacy and Safety of LICART ( diclofenac epolamine), DHEP) Topical System in the Emergency Department: A prospective Observational Study | $31,175 | 0 | 2 |
| Liquid Thyroxine Improved Outcomes in Hypothyroid Patients with Small Intestinal Bacterial Overgrowth Syndrome (SIBO) | $13,928 | 0 | 4 |
| Efficacy and Safety of Licart (Diclofenac Epolamine, DHEP) Topical System 1.3% in Patients with Acute Back Pain: A Prospective Observational Study | $9,853 | 0 | 4 |
| Use of Liquid Stable Levothyroxine in Trisomy 21 Pediatric Patients | $9,100 | 0 | 1 |
| Efficacy and Safety of LICART (diclofenac epolamine, DHEP) Topical System in the Emergency Department: A Prospective Observational Study | $6,115 | 0 | 1 |
Payments by Medical Specialty
Top Paid Doctors — Page 2
| Doctor | Specialty | Location | Total | 2024 |
|---|---|---|---|---|
| Dr. Farhad Zangeneh, Md, MD | Endocrinology, Diabetes & Metabolism | Sterling, VA | $4,377 | $0 |
| Trevor Angell, Md, MD | Internal Medicine | Los Angeles, CA | $4,267 | $0 |
| Dr. Neal Breit, M.d, M.D | Endocrinology, Diabetes & Metabolism | Westwood, NJ | $4,075 | $0 |
| Lori Gerber, Do, DO | Family Medicine | Bensalem, PA | $4,059 | $0 |
| Dr. Matthew Bassan, D.o, D.O | Family Medicine | Wayne, NJ | $4,000 | $0 |
| Isaac Sachmechi, Md, MD | Endocrinology, Diabetes & Metabolism | New Hyde Park, NY | $3,901 | $0 |
| Alexander Tessnow, Md, MD | Endocrinology, Diabetes & Metabolism | Dallas, TX | $3,873 | $0 |
| Dr. Marc Pietropaoli, Md, MD | Sports Medicine | Skaneateles, NY | $3,750 | $0 |
| Elaine Drobny, M.d, M.D | Endocrinology, Diabetes & Metabolism | Milwaukee, WI | $3,618 | $0 |
| Yuvraj Kumbkarni, M.d, M.D | Endocrinology, Diabetes & Metabolism | Tampa, FL | $3,602 | $0 |
| Dr. Harold Pretorius, M.d, M.D | Nuclear Medicine | Cincinnati, OH | $3,501 | $0 |
| Brett Chatman, Dpm, DPM | Surgery | Philadelphia, PA | $3,379 | $0 |
| Denis Becker, Md, MD | Endocrinology, Diabetes & Metabolism | Raleigh, NC | $3,355 | $0 |
| Minh Mach, M.d, M.D | Specialist | Toluca Lake, CA | $3,260 | $0 |
| Dr. Fawad Rizvi, D.o, D.O | Interventional Pain Medicine | Farmington Hills, MI | $3,092 | $0 |
| Mr. Joseph Fallon, M.d, M.D | Endocrinology, Diabetes & Metabolism | Stratford, NJ | $3,015 | $0 |
| Dr. David Golden, M.d, M.D | Sports Medicine | Beverly Hills, CA | $3,000 | $0 |
| Dr. Giuseppe Barbesino, Md, MD | Internal Medicine | Boston, MA | $2,808 | $0 |
| Antonio Bianco, M.d, M.D | Internal Medicine | Chicago, IL | $2,808 | $0 |
| Kelly Wirfel, M.d, M.D | Endocrinology, Diabetes & Metabolism | Bellaire, TX | $2,683 | $0 |
| Kerem Ozer, M.d, M.D | Internal Medicine | Round Rock, TX | $2,614 | $0 |
| Wahid Kassar, M.d, M.D | Endocrinology, Diabetes & Metabolism | Chicago, IL | $2,606 | $0 |
| Dr. Theofanis Mitsinikos, D.o, D.O | Endocrinology, Diabetes & Metabolism | Stony Brook, NY | $2,449 | $0 |
| Melissa Prince Martin | Adult Health | Scottsdale, AZ | $2,287 | $0 |
| Azeez Farooki, Md, MD | Endocrinology, Diabetes & Metabolism | New York, NY | $2,189 | $0 |
About IBSA Pharma Inc.
IBSA Pharma Inc. has made $1.5M in payments to 17,143 healthcare providers, recorded across 51,027 transactions in the CMS Open Payments database. In 2024, the company paid $263,411. The top product by payment volume is Tirosint ($1.1M).
Payments were distributed across 190 medical specialties. The top specialty by payment amount is Endocrinology, Diabetes & Metabolism ($353,787 to 1,568 doctors).
Payment categories include: Food & Beverage ($956,604), Consulting ($285,525), Research ($202,991), Travel & Lodging ($16,238).
IBSA Pharma Inc. is associated with 2 products in the CMS Open Payments database.